Physician

Abeer Arain, M.D., M.P.H

According to 2025 Medicare claims, Abeer Arain, M.D., M.P.H (NPI: 1962851519) practices medical oncology in the Lewiston, ID-WA market, with the plurality of this provider's patient population coming from Nez Perce, ID. This provider's primary affiliated billing organization is ST JOSEPH HOSPITAL LLC (NPI: 1205368404; TIN: 36-4851166) and primary practice location at 83501-2431. Arain is affiliated with the Kootenai Accountable Care, LLC (ACO ID: A3621), Caravan Collaborative Pathways (ACO ID: A4604), AdvantagePoint Health Alliance - Northwest, LLC (ACO ID: A5025), Caravan Health ACO 50 LLC (ACO ID: A5160), and Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Arain's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 335 traditional Medicare patients, billed 832 HCPCS/CPT codes, and received $63,973 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 798 prescription claims across 163 beneficiaries totaling $1,786,584 in drug costs, led by Pomalyst (Pomalidomide). DME data shows 31 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $378 to $1,786,584. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	214	357	$28,792
2023	363	854	$74,417
2024	335	832	$63,973

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	N/R	20	$378
2017	18	34	$623
2018	21	44	$2,457
2019	N/R	25	$3,691
2020	N/R	17	$3,684
2021	N/R	11	$3,378
2022	52	150	$219,679
2023	140	702	$1,205,792
2024	163	798	$1,786,584

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	31	$1,011

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	48	48	$130
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	59	115	$102
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	50	50	$97
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	286	600	$68
G2212	Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or	15	17	$23

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Pomalyst	Pomalidomide	13	364	$298,570
Lenalidomide	Lenalidomide	18	483	$294,571
Jakafi	Ruxolitinib Phosphate	18	540	$292,303
Imbruvica	Ibrutinib	16	448	$261,702
Calquence	Acalabrutinib Maleate	12	360	$181,467

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J8521	Capecitabine, oral, 500 mg	N	N/R	19	$860
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	12	$150

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Abeer Arain, M.D., M.P.H?

Tedicare shows public-source Medicare data for Abeer Arain, M.D., M.P.H (NPI 1962851519), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abeer Arain, M.D., M.P.H have ACO affiliation data?

Abeer Arain, M.D., M.P.H is shown with ACO affiliation data for Kootenai Accountable Care, LLC (MSSP, ACO ID A3621), Caravan Collaborative Pathways (MSSP, ACO ID A4604), AdvantagePoint Health Alliance - Northwest, LLC (MSSP, ACO ID A5025), Caravan Health ACO 50 LLC (MSSP, ACO ID A5160), and Collaborative ACO 30, LLC (MSSP, ACO ID A5483).

What billing organization is linked to Abeer Arain, M.D., M.P.H?

Abeer Arain, M.D., M.P.H is linked to ST JOSEPH HOSPITAL LLC (billing NPI 1205368404) in the available physician profile data.

Does Abeer Arain, M.D., M.P.H have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.